Q3 2024 13F Holders as of 30 Sep 2024
-
Type / Class
-
Equity / NY ARCA BIOTECH
-
Total 13F shares
-
3,138,298
-
Share change
-
-309,144
-
Total reported value
-
$539,316,109
-
Price per share
-
$171.93
-
Number of holders
-
251
-
Value change
-
-$51,186,933
-
Number of buys
-
82
-
Number of sells
-
119
Institutional Holders of FIRST TR EXCHANGE-TRADED FD - NY ARCA BIOTECH (FBT) as of Q3 2024
As of 30 Sep 2024 FIRST TR EXCHANGE-TRADED FD - NY ARCA BIOTECH (FBT) had 251 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 3,138,298 shares of stock of the company.
Largest 10 holders included MORGAN STANLEY, UBS Group AG, WELLS FARGO & COMPANY/MN, LPL Financial LLC, Royal Bank of Canada, Berger Financial Group, Inc, ENVESTNET ASSET MANAGEMENT INC, Raymond James Financial Services Advisors, Inc., RAYMOND JAMES & ASSOCIATES, and D.A. DAVIDSON & CO..
This table shows 252 institutional shareholders of the security as of 30 Sep 2024.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.